[1] Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions[J]. Glycobiology, 2012, 22(7): 880-896. DOI: 10.1093/glycob/cws057.
[2] Yamamoto K, Takahashi K, Shiozaki K, et al. Potentiation of epidermal growth factormediated oncogenic transformation by sialidase NEU3 leading to Src activation[J]. PLoS One, 2015, 10(3): e0120578. DOI: 10.1371/journal.pone.0120578.
[3] Rodriguez-Walker M, Daniotti JL. Human sialidase Neu3 is S-acylated and behaves like an integral membrane protein[J]. Sci Rep, 2017, 7(1): 4167. DOI: 10.1038/s41598-017-04488-w.
[4] Tringali C, Lupo B, Silvestri I, et al. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling[J]. J Biol Chem, 2012, 287(51): 42835-42845. DOI: 10.1074/jbc.M112.407718.
[5] Shiga K, Takahashi K, Sato I, et al. Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis[J]. Cancer Sci, 2015, 106(11): 1544-1553. DOI: 10.1111/cas.12810.
[6] Shi Z, Zhou H, Pan B, et al. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray[J]. Mol Med Rep, 2017, 16(5): 7423-7431. DOI: 10.3892/mmr.2017.7577.
[7] PosthumaDeBoer J, Witlox MA, Kaspers GJ, et al. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature[J]. Clin Exp Metastasis, 2011, 28(5): 493-503. DOI: 10.1007/s10585-011-9384-x.
[8] 陈阳, 吴英良, 山形贞子, 等. 细胞质唾液酸酶(Neu2)通过Cdk2通路抑制FBJ-LL细胞生长[J]. 沈阳药科大学学报, 2010, (2): 147-151.
[9] Sandhu R, Lal H, Kundu ZS, et al. Serum fluoride and sialic acid levels in osteosarcoma[J]. Biol Trace Elem Res, 2011, 144(1-3): 1-5. DOI: 10.1007/s12011-009-8382-1.
[10] Harrison DJ, Geller DS, Gill JD, et al. Current and future therapeutic approaches for osteosarcoma[J]. Expert Rev Anticancer Ther, 2018, 18(1): 39-50. DOI: 10.1080/14737140.2018.1413939.
[11] Hata K, Tochigi T, Sato I, et al. Increased sialidase activity in serum of cancer patients: identification of sialidase and inhibitor activities in human serum[J]. Cancer Sci, 2015, 106(4): 383-389. DOI: 10.1111/cas.12627.
[12] Miyagi T, Takahashi K, Hata K, et al. Sialidase significance for cancer progression[J]. Glycoconj J, 2012, 29(8-9): 567-577. DOI: 10.1007/s10719-012-9394-1.
[13] Lin H, Hao Y, Zhao Z, et al. Sirtuin 6 contributes to migration and invasion of osteosarcoma cells via the ERK1/2/MMP9 pathway[J]. FEBS Open Bio, 2017, 7(9): 1291-1301. DOI: 10.1002/2211-5463.12265. |